Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/57469
Title: | Virtual reality for COPD exacerbation: A randomized controlled trial | Authors: | Kizmaz, Erhan Telli, Atalay, O. Çetin, N. Uğurlu, E. |
Keywords: | COPD Exacerbation Pulmonary rehabilitation Virtual reality C reactive protein adult anxiety anxiety disorder Article chronic obstructive lung disease controlled study COPD assessment test cycling daily life activity depression disease exacerbation dyspnea exercise female forced expiratory volume forced vital capacity functional status Hospital Anxiety and Depression Scale hospitalization human leisure major clinical study male middle aged neurorehabilitation protein blood level pulmonary rehabilitation randomized controlled trial self care single blind procedure sit-to-stand test virtual reality aged anxiety disease exacerbation etiology kinesiotherapy pathophysiology procedures psychology rehabilitation therapy treatment outcome Activities of Daily Living Aged Anxiety Depression Disease Progression Dyspnea Exercise Therapy Female Humans Male Middle Aged Pulmonary Disease, Chronic Obstructive Treatment Outcome Virtual Reality |
Publisher: | W.B. Saunders Ltd | Abstract: | Background: Pulmonary rehabilitation (PR) is an effective treatment method for chronic obstructive pulmonary disease (COPD). However, individuals with chronic diseases that require lifelong treatment and experience exacerbations need motivational methods. Objectives: The aim of this study was to examine the effects of virtual reality on symptoms, daily living activity, functional capacity, anxiety and depression levels in COPD exacerbation. Methods: Fifty patients hospitalized for COPD exacerbation were included in the study. They were randomly assigned to two groups. Twenty-five patients participated in a traditional PR (once-daily until discharge), including pedaling exercises. The second/25 patients followed the same protocol but experienced cycling simulation in the forest via virtual reality (VR + PR). All patients were evaluated using 1-minute/Sit-to-Stand test (STST), modified-Medical Research Council (mMRC) scale, COPD Assessment test (CAT), Hospital Anxiety and Depression Scale (HADS), and London Chest Activities of Daily Living (LCADL) before and after the treatment. Results: The STST showed an increase in both groups post-treatment, notably higher in the VR + PR (p = 0.037). Dyspnea levels and CAT scores decreased in all patients, but the decrease was greater in the PR + VR group for both parameters (p = 0.062, p = 0.003; respectively). Both groups experienced a reduction in the HADS scores compared to the pre-treatment, with a more significant decrease in depression and the total score in the VR + PR (p < 0.05). LCADL's sub-parameters and total score, excluding household, decreased in both groups after treatment (p < 0.05). The improvement was more substantial in the VR + PR. Conclusions: Virtual reality provides benefits in the management of COPD exacerbations and can be used safely. Clinical trial registiration: Registered at clinicaltrials.gov, registration ID: NCT05687396, URL: www.clinicaltrials.gov. © 2024 Elsevier Ltd | URI: | https://doi.org/10.1016/j.rmed.2024.107696 https://hdl.handle.net/11499/57469 |
ISSN: | 0954-6111 |
Appears in Collections: | Fizyoterapi ve Rehabilitasyon Fakültesi PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.